Skip to content

Reducing the burden of disease: Communicable and not Communicable

GUY.01 Reducing the burden of disease: communicabl

Implementation of basic quality control tests for malaria medicines in Amazon Basin countries: results for the 2005-2010 period

Print E-mail

Abstract

Background

Ensuring the quality of malaria medicines is crucial in working toward malaria control andeventual elimination. Unlike other validated tests that can assess all critical quality attributes,which is the standard for determining the quality of medicines, basic tests are significantlyless expensive, faster, and require less skilled labour; yet, these tests provide reproducibledata and information on several critical quality attributes, such as identity, purity, content,and disintegration. Visual and physical inspection also provides valuable information aboutthe manufacturing and the labelling of medicines, and in many cases this inspection is sufficient to detect counterfeit medicines. The Promoting the Quality of Medicines (PQM) programme has provided technical assistance to Amazon Malaria Initiative (AMI) countries to implement the use of basic tests as a key screening mechanism to assess the quality of malaria medicines available to patients in decentralized regions.  

icon Implementation of basic quality control tests for malaria medicines in Amazon (693.89 kB)

Quality of anti-malarials collected in the private and informal sectors in Guyana and Suriname

Print E-mail

 Abstract

Background

Despite a significant reduction in the number of malaria cases in Guyana and Suriname, this disease remains a major problem in the interior of both countries, especially in areas with gold mining and logging operations, where malaria is endemic. National malaria control programmes in these countries provide treatment to patients with medicines that are procured and distributed through regulated processes in the public sector. However, availability to medicines in licensed facilities (private sector) and unlicensed facilities (informal sector) is common, posing the risk of access to and use of non-recommended treatments and/or poor quality products.

icon Quality of anti-malarials collected in the private and informal sectors in Guyana and Suriname (257.1 kB)

 

Last Updated on Wednesday, 11 July 2012 09:17

Strengthening Laboratory Capacity for Diagnosis and Management of Chagas Disease for Primary HealthCare Workshop

Print E-mail

 The Ministry of Health in collaboration with the Pan American Health Organization/World Health Organization (PAHO/WHO) conducted a three-day training for primary health care personnel on strengthening laboratory capacity for diagnosis and management of Chagas disease. Twenty-eight (28) persons participated in the training, which was held from 26 to 28 June 2012 at the National Reference Laboratory, Georgetown. Clinicians participated in the first day of the training and laboratory technicians participated the following two days.

The three-day workshop was facilitated by Dr. Alejandro Luquetti, Professor, University of Brazil.

Dr. Shamdeo Persaud, Chief Medical Officer, Ministry of Health, in his opening remarks welcomed the participants and highlighted the importance of the training.  He stated that the focus is to create awareness of the Chagas disease, and to explore diagnosis criteria and management and treatment of the disease. He further mentioned that in Guyana, evidence gathered from blood bank screening and small studies done indicates there are positive cases of Chagas disease.

Dr. Nicolas Ceron, PAHO/WHO Specialist, Malaria Prevention and Control, stated that with the increase in international travel and open borders, especially in South and Central America, the disease is now globally distributed. The prevalence of Chagas disease in the Amazon is estimated at about 3% with 10-14 million cases. Incidence is estimated at about 1.5 million annually, due to increased access to habitat of the vector of transmission.  He further stated that efforts to interrupt the transmission of Chagas disease have been successful in several countries and must continue through vector control and blood bank screening. Transmission by blood transfusion has increasingly been reported as the cause of new infections outside the foci natural transmission.

Dr. Ceron advised that all of these strategies are in the local Neglected Tropical Diseases (NTD) plan and that training was important in order to continue the implementation of the Chagas plan in Guyana.

Last Updated on Wednesday, 11 July 2012 09:23

IMAI Training of Trainers Workshop in Region 6

Print E-mail

Berbice, Guyana, 05 May 2012 (PAHO/WHO) Improving community based responses to the prevention, management and monitoring of adolescent and adult illnesses including HIV and TB has been the focus of an intensive two day Training of Trainers (TOT) workshop conducted by the Ministry of Health (MOH) in collaboration with the Pan American Health Organization/World Health Organization (PAHO/WHO) held from the 4th to the 5th June.
The two objectives achieved from the IMAI TOT workshop were:
1.    To refresh the IMAI trainers on the updated IMAI training tools and modules
2.    To certify the trainers

The IMAI facilitator and participant manuals and its modules were updated based on the National Guidelines for Management of HIV-Infected and HIV-Exposed Adults and Children, 2010-2011 Revision.

A total of 5 facilitators conducted the IMAI TOT and the five IMAI modules were able to be taught:
1.    Acute Care for adolescents and adults
2.    Chronic HIV Care, with antiretroviral therapy (ART)
3.    General Principles of Good Chronic Care
4.    Palliative Care, addressing symptom management and end of life care
5.    TB/HIV Co-management

The IMAI which was adapted and updated from WHO generic training tools was utilized for the TOT workshop which was attended by 12 physicians, 1 MEDEX and 4 Nurse Midwives and numerous allied health care workers.

 

Last Updated on Monday, 25 June 2012 09:23
Read more...

Guyana Observe World No Tobacco Day 31 May 2012

Print E-mail

 STOP TOBACCO INDUSTRY INTERFERENCE IN TOBACCO CONTROL

CURBING THE TOBACCO EPIDEMIC

Tobacco addiction is a global epidemic that ravages entire countries and regions, wreaking the most havoc in the most vulnerable countries and creating an enormous toll of disability, disease, lost productivity and death. Tobacco use continues to be the leading global cause of preventable death. It kills nearly 6 million people every year through cancer, heart disease, respiratory diseases, childhood diseases and others. It also causes hundreds of billions of dollars of economic losses worldwide every year. If current trends continue, by 2030 tobacco will kill more than 8 million people worldwide every year, with 80% of these premature deaths occurring among people in low- and middle-income countries. Over the course of the 21st century, tobacco use could kill up to a billion people unless urgent action is taken.

icon World NoTobacco Day brochure (410.41 kB)

 

Last Updated on Wednesday, 30 May 2012 18:03
<< Start < Prev 1 2 3 4 5 6 7 Next > End >>

Page 4 of 7

Lot 8 Brickdam Stabroek, Georgetown, Guyana, P.O. Box 10969 ,Georgetown, Guyana
Tel.: +592 225-3000; +592 227-5150; +592 227-5158; +592 227-5159;+592 227-6371; +592 223-6372
Fax: +592 226-6654; +592 227-4205 email e-mail@guy.paho.org